Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule.
Nagy, C F
Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. [electronic resource] - Clinical and translational science 01 2017 - 12-19 p. digital
Publication Type: Journal Article
1752-8062
10.1111/cts.12433 doi
Animals
Anthrax--drug therapy
Antibodies, Monoclonal--administration & dosage
Antitoxins--administration & dosage
Dose-Response Relationship, Drug
Humans
Macaca fascicularis
Rabbits
Respiratory Tract Infections--drug therapy
Time Factors
Translational Research, Biomedical
United States
United States Food and Drug Administration
Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. [electronic resource] - Clinical and translational science 01 2017 - 12-19 p. digital
Publication Type: Journal Article
1752-8062
10.1111/cts.12433 doi
Animals
Anthrax--drug therapy
Antibodies, Monoclonal--administration & dosage
Antitoxins--administration & dosage
Dose-Response Relationship, Drug
Humans
Macaca fascicularis
Rabbits
Respiratory Tract Infections--drug therapy
Time Factors
Translational Research, Biomedical
United States
United States Food and Drug Administration